Home
Company
Therapeutic Focus
Pipeline
Oxylanthanum Carbonate (OLC)
UNI-494
Investors
Resources
Careers
Contact
All SEC Filings
Investors
Investors
Overview
News
Events & Presentations
IR Calendar
Presentations
Governance
Overview
Management Team
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Financial & Stock Info
Overview
Financial Results
Quote
Charts
Historical Data
Analyst Coverage
Resources
Overview
Contacts
FAQ
Email Alerts
Filing Type:
View All
10-K
10-Q
3
4
4/A
424B3
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-Q
POS AM
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2025
2024
2023
2022
2021
2020
2019
Date
Form
Description
PDF
XBRL
Pages
11/13/24
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
11/13/24
POS AM
Post-effective amendment to a registration statement that is not immediately effective upon filing
2
11/13/24
8-K
Current report filing
Documents
expand_more
EX-99.1
5
11/13/24
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
expand_more
EX-3.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
33
11/12/24
8-K
Current report filing
Documents
expand_more
EX-99.1
4
10/11/24
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
10/10/24
4
Statement of changes in beneficial ownership of securities
1
09/25/24
8-K
Current report filing
2
08/14/24
4
Statement of changes in beneficial ownership of securities
1
08/14/24
4
Statement of changes in beneficial ownership of securities
1
rss_feed
Filing RSS
arrow_back
1
2
3
4
5
6
7
8
9
10
…21
arrow_forward
Email Alerts
Contacts
RSS News Feed